Co-Diagnostics, Inc.

Drug Name	Phase	Indication	Designations	Patent
pemetrexed	Phase 3	Non-Small Cell Lung Cancer	-	-
SPM 962	Phase 3	Parkinson's Disease	-	-
OPC-41061(Tolvaptan)	Phase 3	Heart Failure, Congestive	-	-
Cilostazol	Phase 3	Vasospastic Angina	-	-
SEP-363856	Phase 3	Schizophrenia	-	-
OPC-34712FUM/ Brexpiprazole fumarate	Phase 3	Schizophrenia	-	-
Tolvaptan	Phase 3	Pediatric Congestive Heart Failure (CHF) Patients With Volume Overload	-	-
Nalmefene hydrochloride	Phase 3	Alcohol Dependence	-	-
EPs® 7630	Phase 3	Common Cold	-	-
NOMAC-E2	Phase 3	Contraception	-	-
MK0476, montelukast sodium	Phase 3	Rhinitis, Allergic, Seasonal	-	-
ezetimibe (+) simvastatin	Phase 3	Cardiovascular Disorder	-	-
WO3970	Phase 3	Primary Axillary Hyperhidrosis	-	-
Rescue medication	Phase 3	Bipolar Disorder	-	-
MK0954, /Duration of Treatment : 16 Weeks	Phase 3	Hypertension	-	-
Olanzapine	Phase 3	Bipolar Disorder	-	-
Simvastatin 20 mg	Phase 3	Hypercholesterolemia	-	-
Ciprofol	Phase 3	Gynecological Outpatient Surgery	-	-
HSK7653 25 mg Q2W	Phase 3	Diabetes Mellitus, Type 2	-	-
valsartan 160mg, cilnidipine 10mg, cilinidipine 5mg	Phase 3	Hypertension	-	-
ezetimibe with simvastatin	Phase 3	Hypercholesterolemia	-	-
recombinant birch pollen allergen	Phase 3	Allergy	-	-
HSK7653 10 mg Q2W	Phase 3	Diabetes Mellitus, Type 2	-	-
HSK3486	Phase 3	Induction and Maintenance of General Anesthesia	-	-
ADC189 tablets	Phase 3	Influenza Type A	-	-
VC005 tablets	Phase 3	Non-segmental Vitiligo	-	-
Rizatriptan 5 mg	Phase 3	Migraine Disorders	-	-
Ezetimibe	Phase 3	Hypercholesterolemia	-	-
SCH No. 418131 (Mometasone Furoate/Formoterol Furoate abbreviated MF/F )	Phase 3	Asthma	-	-
SKB264	Phase 3	Non-small Cell Lung Cancer	-	-
mometasone furoate combination MDI 200/10 mcg BID	Phase 3	Asthma	-	-
MK0663, etoricoxib / Duration of Treatment: 6 Weeks	Phase 3	Osteoarthritis	-	-
Tapinarof cream, 1%	Phase 3	Plaque Psoriasis	-	-
Desloratadine 5 mg	Phase 3	Perennial Allergic Rhinitis	-	-
5-mg Desloratadine	Phase 3	Allergic Rhinitis	-	-
MR308	Phase 3	Acute Pain	-	-
Shugan Jieyu Capsules	Phase 3	Generalized Anxiety Disorder	-	-
simvastatin (+) ezetimibe	Phase 3	Hypercholesterolemia	-	-
OPA-15406	Phase 3	Atopic Dermatitis	-	-
daptomycin	Phase 3	Pneumonia, Bacterial	-	-
Montelukast Oral Granules (OG)	Phase 3	Perennial Allergic Rhinitis	-	-
Osimertinib	Phase 3	Non-small Cell Lung Cancer	-	-
loratadine; montelukast	Phase 3	Rhinitis, Allergic, Seasonal	-	-
Tetravalent influenza virus lysis vaccine	Phase 3	Coronavirus Disease 2019	-	-
Tibolone	Phase 3	Osteoporosis	-	-
Liposomal doxorubicin, Paclitaxel or Topotecan	Phase 3	Epithelial Ovarian Cancer	-	-
BL-B01D1	Phase 3	Small Cell Lung Cancer	-	-
Tramadol	Phase 3	Acute Pain	-	-
Allerslit forte	Phase 3	Allergy	-	-
MK0653, ezetimibe	Phase 3	Lipid Metabolism, Inborn Errors	-	-
rolofylline	Phase 3	Heart Failure, Congestive	-	-
allo-APZ2-CVU	Phase 3	Skin Ulcer Venous Stasis Chronic	-	-
OPC-34712	Phase 3	Schizophrenia	-	-
TEV-48125	Phase 3	Migraine	-	-
alendronate	Phase 3	Paget's Disease of Bone	-	-
Atorvastatin 10 mg	Phase 3	Hypercholesterolemia	-	-
Oxycodone	Phase 3	Cancer	-	-
methylphenidate hydrochloride	Phase 3	Attention Deficit Hyperactivity Disorder	-	-
losartan potassium (+) hydrochlorothiazide	Phase 3	Hypertension	-	-
rizatriptan benzoate	Phase 3	Acute Migraine With or Without Aura in Adolescents	-	-
Ezetimibe 10 mg	Phase 3	Hypercholesterolemia	-	-
SCH 900962 / Corifollitropin alfa / Org 36286	Phase 3	Infertility	-	-
Oxycodone nalaxone prolonged release tablets (OXN)	Phase 3	Pain	-	-
MK0217A, alendronate sodium (+) cholecalciferol / Duration of Treatment: 15 weeks	Phase 3	Osteoporosis	-	-
Corifollitropin alfa	Phase 3	Hypogonadotropic Hypogonadism	-	-
Surotomycin	Phase 3	Clostridium Difficile Infection	-	-
MK0217, alendronate sodium / Duration of Treatment : 2 Years	Phase 3	Osteoporosis, Postmenopausal	-	-
EZ 10 mg/Atorva 20 mg FDC	Phase 3	Hypercholesterolemia	-	-
Propofol	Phase 3	Sedation in Intensive Care	-	-
MK0663, etoricoxib	Phase 3	Osteoarthritis	-	-
Grass pollen allergens in a water/glycerol solution	Phase 3	Allergic Rhinoconjunctivitis	-	-
Eptifibatide (Integrilin)	Phase 3	Myocardial Ischemia	-	-
simvastatin	Phase 3	Hypercholesterolemia	-	-
ELIXCYTE	Phase 3	Knee Osteoarthritis	-	-
Allergovit 6-grasses	Phase 3	Grass Pollen Allergy	-	-
Aripiprazole Oral Solution	Phase 3	Tourette Syndrome	-	-
Hetrombopag	Phase 3	Immune Thrombocytopenia	-	-
wasp venom	Phase 3	Allergy	-	-
Grass pollen specific immunotherapy	Phase 3	Rhinoconjunctivitis	-	-
KHK4827	Phase 3	Moderate to Severe Plaque Psoriasis	-	-
180mg of ETC-1002(bempedoic acid)	Phase 3	Hypercholesterolemia	-	-
MK0462, rizatriptan benzoate / Duration of Treatment -1day	Phase 3	Migraine	-	-
semaglutide injection	Phase 3	Diabetes Mellitus, Type 2	-	-
AL0704rP	Phase 3	Rhinoconjunctivitis	-	-
Tibolone 2.5 mg	Phase 3	Postmenopausal Women	-	-
bee venom	Phase 3	Bee Venom Allergy	-	-
Grass pollen formulation	Phase 3	Grass Pollen Allergy	-	-
Recombinant birch pollen	Phase 3	Birch Pollen Allergy	-	-
Acaroid	Phase 3	Respiratory Hypersensitivity	-	-
specific immunotherapy with Acaroid, subcutaneously, Up-titration till strength B 0.6 mL (6000 TU)	Phase 3	Rhinoconjunctivitis	-	-
ESAT6-CFP10 (10ug/ml) in left arm and TB-PPD in right arm	Phase 3	Tuberculosis	-	-
desloratadine	Phase 3	Chronic Idiopathic Urticaria	-	-
Thioctic Acid	Phase 3	Diabetic Polyneuropathy	-	-
CARTISTEM	Phase 3	Degenerative Osteoarthritis	-	-
Recombinant Mycobacterium Tuberculosis Fusion Protein	Phase 3	Latent Tuberculosis Infection	-	-
Sotatercept	Phase 3	Pulmonary Arterial Hypertension	-	-
ibandronate	Phase 3	Postmenopausal Osteoporosis	-	-
Tafasitamab	Phase 3	DLBCL	-	-
MK0663, Etoricoxib / Duration of Treatment : 12 Weeks	Phase 3	Recurrent Low Back Pain	-	-
HSK21542	Phase 3	Pruritus	-	-
Bacillus Calmette - Guerin	Phase 3	Tuberculosis	-	-
Fidaxomicin	Phase 3	Clostridium Infections	-	-
FOSAVANCE 5600 (Alendronate Sodium (+) cholecalciferol)	Phase 3	Osteoporosis	-	-
Atorvastatin	Phase 3	Hypercholesterolemia	-	-
Salmeterol xinafoate	Phase 3	Exercise Induced Asthma	-	-
HSK21542 Injection	Phase 3	Postoperative Analgesia	-	-
1% OPA-15406 Ointment	Phase 3	Atopic Dermatitis (AD)	-	-
Centanafadine Hydrochloride	Phase 3	Attention Deficit/Hyperactivity Disorder	-	-
Aripiprazole IM Depot	Phase 3	Schizophrenia	-	-
Birch pollen allergoid	Phase 3	Pollen Allergy	-	-
Etoricoxib 90 mg	Phase 3	Pain, Postoperative	-	-
MK0653A (ezetimibe [+] simvastatin)	Phase 3	Hypercholesterolemia	-	-
Asenapine 5 mg	Phase 3	Schizophrenia	-	-
Lasmiditan 50mg	Phase 3	Acute Migraine	-	-
MK-0954A	Phase 3	Hypertension	-	-
Hydronidone capsules	Phase 3	Liver Fibrosis	-	-
CXA-201	Phase 3	Complicated Urinary Tract Infection	-	-
Montelukast	Phase 3	Rhinitis, Allergic, Perennial	-	-
MK0217, /Duration of Treatment : 12 Months	Phase 3	Osteoporosis, Postmenopausal	-	-
Mometasone furoate nasal spray (MFNS)	Phase 3	Rhinitis, Allergic	-	-
Meplazumab for injection	Phase 3	Post-COVID-19	-	-
MK0954, /Duration of Treatment : 5 Years	Phase 3	Hypertension and Left Ventricular Hypertrophy (Thickening of the Main Pumping Chamber of the Heart)	-	-
Asenapine	Phase 3	Psychosis	-	-
Losartan Potassium	Phase 3	Proteinuria	-	-
Recombinant grass pollen	Phase 3	Allergy	-	-
montelukast sodium	Phase 3	Asthma	-	-
Vehicle Cream	Phase 3	Atopic Dermatitis	-	-
Tapinarof	Phase 3	Plaque Psoriasis	-	-
Mometasone Furoate/Formoterol Fumarate Combination MDI 100/10 mcg BID	Phase 3	Asthma	-	-
MK0733 / Duration of Treatment: 18 Weeks	Phase 3	HDL Cholesterol	-	-
MK0906, finasteride / Duration of Treatment: 48 weeks	Phase 3	Benign Prostatic Hyperplasia	-	-
Aripiprazole	Phase 3	Bipolar I Disorder	-	-
Freeze-dried human rabies vaccine (MRC-5 cells) Zhifeilongkoma - 5-dose program	Phase 3	Rabies Vaccine Adverse Reaction	-	-
OPC-41061	Phase 3	Cirrhosis	-	-
Brexpiprazole	Phase 3	Agitation Associated With Dementia of the Alzheimer's Type	-	-
E6011 2 mg/kg	Phase 2	Crohn's Disease	-	-
Palonosetron	Phase 2	Nausea	-	-
MT1013	Phase 2	Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysis	-	-
Ganirelix	Phase 2	Controlled Ovarian Stimulation	-	-
MIL62	Phase 2	Systemic Lupus Erythematosus	-	-
ALC-2203-1	Phase 2	Acute Bronchitis	-	-
BL-M07D1	Phase 2	HER2-positive Breast Cancer	-	-
Treatment A: Azelastine hydrochloride 0.15% nasal spray (Azelair)	Phase 2	Seasonal Allergic Rhinitis	-	-
HSK39004 Dry Powder Inhaler -0.75mg BID	Phase 2	Chronic Obstructive Lung Disease (COLD)	-	-
CTN SR	Phase 2	Adult ADHD	-	-
SHR-1210	Phase 2	Small-cell Lung Cancer	-	-
Ecallantide	Phase 2	Bloodloss	-	-
KUS121 high dose	Phase 2	Central Retinal Artery Occlusion	-	-
Org 36286	Phase 2	Infertility	-	-
ABSK061 + ABSK043	Phase 2	HER2-Gastric/Gastroesophageal Junction Cancer	-	-
Sibeprenlimab	Phase 2	Sjogren Disease	-	-
Dalantercept	Phase 2	Squamous Cell Carcinoma of the Head and Neck	-	-
ADT	Phase 2	Major Depressive Disorder	-	-
MK-3795	Phase 2	VHL Gene Mutation	-	-
PTA + Infusion of MSC_Apceth	Phase 2	Critical Limb Ischemia	-	-
Sotatercept 0.3 mg/kg	Phase 2	Hypertension, Pulmonary	-	-
Oxycodone naloxone prolonged release tablets	Phase 2	Interstitial Cystitis	-	-
Biological: AL0206st	Phase 2	Rhinoconjunctivitis	-	-
E6007	Phase 2	Moderate Active Ulcerative Colitis	-	-
JAB-21822 (KRAS G12C inhibitor)	Phase 2	Advanced Solid Tumor	-	-
HSK31679 80mg	Phase 2	Non-Alcoholic Steatohepatitis (NASH)	-	-
ARQ 197	Phase 2	Non Small Cell Lung Cancer	-	-
Luspatercept	Phase 2	Anemia	-	-
Pneumostem®	Phase 2	Bronchopulmonary Dysplasia	-	-
rBet v1-FV	Phase 2	Allergic Rhinoconjunctivitis	-	-
mometasone furoate/formoterol 100/10 mcg	Phase 2	Asthma	-	-
rPhleum	Phase 2	Type I-Allergy	-	-
Human Heterologous Liver Cells	Phase 2	Urea Cycle Disorders	-	-
rebamipide	Phase 2	Colitis, Ulcerative	-	-
Human umbilical cord blood-derived mesenchymal stem cells	Phase 2	Acute Leukemia	-	-
5μg/ml ESAT6-CFP10 in left arm and TB-PPD in right arm	Phase 2	Tuberculosis	-	-
Tivantinib	Phase 2	Advanced Solid Tumors	-	-
TNTL capsule	Phase 2	Accidental Exposure While Preparing Drug for Administration	-	-
PD P 506 A	Phase 2	Onychomycosis	-	-
HSK3486 0.1-0.2 /0.3 mg / kg group	Phase 2	Sedation	-	-
PD-1 Monoclonal Antibody	Phase 2	Non-small Cell Lung Cancer	-	-
Part1:Recombinant two-component COVID-19 vaccine (CHO cell)	Phase 2	COVID-19	-	-
TLL018 tablets	Phase 2	Plaque Psoriasis	-	-
etonogestrel with testosterone undecanoate	Phase 2	Contraception	-	-
Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection	Phase 2	Rheumatoid Arthritis	-	-
OXN PR followed by OxyPR tablets	Phase 2	Severe Chronic Pain	-	-
Sugar Pill	Phase 2	Osteoarthritis of the Knee	-	-
Recombinant new coronavirus vaccine (CHO cell)	Phase 2	COVID-19	-	-
Test Product HY07121	Phase 2	Safety	-	-
SI-B003	Phase 2	Urothelial Carcinoma	-	-
5-aminolevulinic acid	Phase 2	Glioblastoma	-	-
SB011, 2 % (Water/Oil/Water) emulsion of hgd40	Phase 2	Mild to Moderate Atopic Dermatitis	-	-
Tangning Tongluo Capsule	Phase 2	General Disorders and Administration Site Conditions	-	-
Test Product HYP-6589	Phase 2	Solid Tumor	-	-
Dimethicone	Phase 2	Scalp Psoriasis	-	-
HSK39297 200mgQD	Phase 2	Lupus Nephritis (LN)	-	-
Oxycodone Naloxone	Phase 2	Moderate to Severe Pain Due to Diabetic Polyneuropathy	-	-
JAB-23E73	Phase 2	Advanced Solid Tumor	-	-
OG-6219	Phase 2	Endometriosis	-	-
Recombinant novel coronavirus vaccine (CHO cells)	Phase 2	Prevention of COVID-19	-	-
Gefapixant	Phase 2	Idiopathic Pulmonary Fibrosis	-	-
Formatris 24µg	Phase 2	Asthma	-	-
HSK16149 20mg BID	Phase 2	Diabetic Peripheral Neuropathic Pain	-	-
Etoricoxib 75 mg 4% DMSO Gel	Phase 2	Osteoarthritis Pain	-	-

Regulatory Approvals

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply

Co-Diagnostics, Inc.

Market Overview

CODX News

Catalyst Timeline

Pipeline & FDA Submissions

AI Predictions & Institutional Flow

Market Intelligence

Regulatory Approvals